Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109823496 | 10982349 | 6 | F | 201602 | 20160715 | 20150403 | 20160728 | EXP | US-PFIZER INC-2015017480 | PFIZER | 92.00 | YR | F | Y | 65.31000 | KG | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109823496 | 10982349 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 200 MG, 2X/DAY | 21446 | 200 | MG | CAPSULE, HARD | BID | ||||||
| 109823496 | 10982349 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 200 MG, 2X/DAY | J82634 | 21446 | 200 | MG | CAPSULE, HARD | BID | |||||
| 109823496 | 10982349 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | UNK, 2X/DAY | 21446 | CAPSULE, HARD | BID | ||||||||
| 109823496 | 10982349 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 200 MG, UNK | 21446 | 200 | MG | CAPSULE, HARD | |||||||
| 109823496 | 10982349 | 5 | C | ALBUTEROL. | ALBUTEROL | 1 | Nasal | 2.5 MG PER 3 ML, NEBULIZATION, Q4-6HR AS NEEDED | 0 | ||||||||||
| 109823496 | 10982349 | 6 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 109823496 | 10982349 | 7 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | Oral | 2 DF, DAILY | 0 | 2 | DF | TABLET | |||||||
| 109823496 | 10982349 | 8 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | TABLET | |||||||
| 109823496 | 10982349 | 9 | C | DICLOFENAC POTASSIUM. | DICLOFENAC POTASSIUM | 1 | Oral | 50 MG ORAL TABLET 3 TIMES A DAY (TID), PRN | 0 | 150 | MG | TABLET | |||||||
| 109823496 | 10982349 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 109823496 | 10982349 | 11 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 200 MG, AS NEEDED (50 MG, 4 TIMES A DAY WHEN SHE NEEDS IT) | 0 | 200 | MG | TABLET | |||||||
| 109823496 | 10982349 | 12 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, AS NEEDED | 0 | 50 | MG | TABLET | |||||||
| 109823496 | 10982349 | 13 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 5 MG, AS NEEDED (QHS (EACH NIGHT AT BEDTIME)) | 0 | 5 | MG | TABLET | |||||||
| 109823496 | 10982349 | 14 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | |||||||
| 109823496 | 10982349 | 15 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
| 109823496 | 10982349 | 16 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 30 MG, 1X/DAY | 0 | 30 | MG | TABLET | QD | ||||||
| 109823496 | 10982349 | 17 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
| 109823496 | 10982349 | 18 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 109823496 | 10982349 | 19 | C | AZELASTINE | AZELASTINE | 1 | Nasal | 2 SPRAYS EACH NOSTRIL, 2X/DAY | 0 | 4 | DF | BID | |||||||
| 109823496 | 10982349 | 20 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 109823496 | 10982349 | 21 | C | DULCOLAX NOS | BISACODYL OR DOCUSATE SODIUM | 1 | Oral | DOCUSATE-50 MG, SENNA-8.6 MG ) (ONCE A DAY IN THE EVENING) | 0 | 1 | DF | TABLET | QD | ||||||
| 109823496 | 10982349 | 22 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | 500 MG, 1X/DAY (500 MG TABLET Q 24HR, 10 DAY(S) 10 TABLET AND 7 DAY(S) 7 TABLET) | 0 | 500 | MG | TABLET | QD | ||||||
| 109823496 | 10982349 | 23 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 20 MEQ, 2X/DAY | 0 | 20 | MEQ | PROLONGED-RELEASE TABLET | BID | ||||||
| 109823496 | 10982349 | 24 | C | POLYETHYLENE GLYCOL 3350. | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 17 G, 1X/DAY | 0 | 17 | G | QD | |||||||
| 109823496 | 10982349 | 25 | C | VISTARIL | HYDROXYZINE PAMOATE | 1 | Oral | 100 MG, AS NEEDED (25 MG QID PRN) | 0 | 100 | MG | CAPSULE | |||||||
| 109823496 | 10982349 | 26 | C | MULTIVITAMINS | VITAMINS | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | TABLET | |||||||
| 109823496 | 10982349 | 27 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD | ||||||||
| 109823496 | 10982349 | 28 | C | LAXATIVE | UNSPECIFIED INGREDIENT | 1 | UNK, 1X/DAY (CAP FULL EVERY MORNING) | 0 | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109823496 | 10982349 | 1 | Neuralgia |
| 109823496 | 10982349 | 2 | Neuropathy peripheral |
| 109823496 | 10982349 | 3 | Pain |
| 109823496 | 10982349 | 5 | Wheezing |
| 109823496 | 10982349 | 6 | Dyspnoea |
| 109823496 | 10982349 | 9 | Pain |
| 109823496 | 10982349 | 11 | Pain |
| 109823496 | 10982349 | 13 | Sleep disorder |
| 109823496 | 10982349 | 25 | Pruritus |
| 109823496 | 10982349 | 27 | Neuralgia |
| 109823496 | 10982349 | 28 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109823496 | 10982349 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109823496 | 10982349 | Body height decreased | |
| 109823496 | 10982349 | Bronchitis | |
| 109823496 | 10982349 | Burning sensation | |
| 109823496 | 10982349 | Chills | |
| 109823496 | 10982349 | Condition aggravated | |
| 109823496 | 10982349 | Cough | |
| 109823496 | 10982349 | Drug dose omission | |
| 109823496 | 10982349 | Drug ineffective | |
| 109823496 | 10982349 | Fall | |
| 109823496 | 10982349 | Fatigue | |
| 109823496 | 10982349 | Foot fracture | |
| 109823496 | 10982349 | Gingival swelling | |
| 109823496 | 10982349 | Hyperhidrosis | |
| 109823496 | 10982349 | Hypersensitivity | |
| 109823496 | 10982349 | Hypoacusis | |
| 109823496 | 10982349 | Influenza | |
| 109823496 | 10982349 | Insomnia | |
| 109823496 | 10982349 | Intentional product misuse | |
| 109823496 | 10982349 | Malaise | |
| 109823496 | 10982349 | Nasal congestion | |
| 109823496 | 10982349 | Nausea | |
| 109823496 | 10982349 | Pain | |
| 109823496 | 10982349 | Pain in extremity | |
| 109823496 | 10982349 | Protein total decreased | |
| 109823496 | 10982349 | Sebaceous carcinoma | |
| 109823496 | 10982349 | Spinal deformity | |
| 109823496 | 10982349 | Swollen tongue | |
| 109823496 | 10982349 | Viral upper respiratory tract infection | |
| 109823496 | 10982349 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109823496 | 10982349 | 2 | 20141028 | 0 |